FILE - This September 2020 photo provided by Johnson & Johnson shows a single-dose COVID-19 vaccine being developed by the company. A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot, the company announced Monday, Oct. 12, 2020.

For a second consecutive day, no COVID-19-related deaths were recorded in the country. However, 40 additional cases were confirmed by the Ministry of Health, bringing the total number of people to be infected locally up to 5,194.

The figures were confirmed in the ministry’s daily update yesterday but it noted that the number of positive cases reported usually reflects the samples taken during the previous three days and not the last 24 hours. The update also indicated that 204 people were tested for the virus within the last 24 hours.

The number of active cases also continued to decrease yesterday, following the release of 50 people from the ministry’s care: 10 were discharged from public health facilities while 40 were released from home self-isolation. These releases brought the total number of people to recover from the virus locally up to 3,502.

Of the 1,599 active cases, the ministry said 1,465 were in home self-isolation with 95 patients remaining in hospital and 39 in step-down/transitional facilities.

The ministry’s update indicated that those remaining in hospital were spread across four facilities: 59 at the Couva multi-Training Facility, 17 at the Caura Hospital, two at the Arima General Hospital and 17 at the Scarborough Regional Hospital. Those in step-down/transitional facilities were spread across three facilities: 26 at the Claxton Bay Correctional Facility, ten at the UWI Debe Campus and three in Tobago.

There were also 231 people in state quarantine facilities.